Pre-market hot trades in US stocks: Critical Metals up 10.26% pre-market; K-Tech Solutions down 10.07% pre-market

Pre-market Hot Trades in US Stocks Critical Metals is up 10.26% in pre-market trading. According to recent important news: On October 17, Critical Metals sold 3.03 million shares at a price of $16.50 per share. This sale may indicate that the company is raising funds or adjusting its shareholder structure, leading to an increase in stock price. On October 17, market analysts rated Critical Metals as a sell, yet the stock remains in the spotlight for investors, possibly due to increased demand for critical minerals. On October 18, market analysts noted that although Critical Metals was not included in the recommended buy list, five other stocks were considered better investment choices, which may impact investor sentiment. The demand for critical minerals is increasing, and market volatility risk is high. K-Tech Solutions is down 10.07% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Top Gainers in Pre-market US Stocks Celcuity is up 73.21% in pre-market trading. According to recent important news: On October 18, Celcuity announced the latest progress of its Phase 3 VIKTORIA-1 clinical trial for the PIK3CA mutation cohort. The trial evaluated the effectiveness of gedatolisib in combination with fulvestrant, showing a significant reduction in the risk of disease progression or death in HR-positive, HER2-negative, PIK3CA-mutated tumor patients. This news drove a substantial increase in stock price. On October 18, Celcuity released updated results from its Phase 1 clinical trial, showing positive clinical outcomes for gedatolisib in combination with Nubeqa® in mCRPC patients. These patients had disease progression after previous treatments, and the new data enhanced market confidence in the company's R&D capabilities. On October 18, Celcuity initiated a rolling new drug application submission, expected to be completed in the fourth quarter of 2025. This progress indicates the company's active advancement in its R&D pipeline, further boosting investor confidence. The biotechnology sector has performed strongly recently, with noticeable capital inflow. Beyond Meat is up 71.93% in pre-market trading. According to recent important news: On October 16, Beyond Meat announced the lifting of lock-up restrictions on 316,150,176 new shares. This news sparked market expectations for increased liquidity of the company's stock, leading to a substantial rise in stock price. On October 17, investors took a bearish stance on Beyond Meat, reflected in options trading. This indicates a divergence in market expectations regarding the company's future performance, increasing stock price volatility Recently, there are no other important news. The plant-based meat industry is experiencing increased volatility, and risks need to be monitored. FGI Industries, pre-market up 61.76%, has no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation